(EMAILWIRE.COM, May 26, 2017 ) Browse 85 market data tables and 27 figures spread through 250 pages and in-depth TOC on “Angiography Devices Market”
http://www.marketsandmarkets.com/Market-Reports/angiography-devices-market-189521618.html
Early buyers will receive 10% customization on this report.

Growth in this market is attributed to the rising demand for exact diagnosis & treatment of cardiovascular disease, advancement in technology, and new product launches. However, the high cost of these devices, lack of reimbursement, and stringent regulatory requirements are curbing market growth to a certain extent.

The global angiography devices market is segmented by technology, product, application, procedure, indication, end users, and region.

Get The PDF Brochure For This Report:
http://www.marketsandmarkets.com/pdfdownload.asp?id=189521618

It also discusses the key market drivers, restraints, opportunities, and challenges of this market and its submarkets. The market, by products, is segmented into angiography systems, catheters, guide-wires, balloons, contrast media, vascular closure devices, and accessories.

North America, a major market for global angiography devices, occupied a major share in this market, closely followed by Europe. However, emerging countries from Asia and the Rest of the World (Latin America) are expected to record strong growth during the forecast period. Countries like India, China, and Brazil will majorly drive market growth, owing to rising investments by public & private players to provide improved healthcare services in these countries, the presence of a large patient population, and the focus of leading players on capturing growth opportunities in these markets.

Request for the Customized Information:
http://www.marketsandmarkets.com/requestCustomization.asp?id=189521618

Major players in the angiography devices market are Siemens Healthcare (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Shimadzu Corporation (Japan), Royal Philips Electronics (Netherlands), St. Jude Medical, Inc. (U.S.), and Abbott Vascular (Abbott Laboratories) (U.S.).

About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441